GRACEcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.

Dr. Jack West describes his evolving perspective on the yield of testing for molecular markers, which is leading him to become more optimistic about testing a broader range of people with NSCLC.

Direct download: GRACEcastUC-012_Lung-Video_More_You_Seek_More_You_Find.m4v
Category:Lung-Cancer-Video -- posted at: 12:33pm PST

Dr. Hy Muss reviews potential benefits of treatment for advanced, metastatic breast cancer, as well as the value of functional assessment of patients to predict treatment tolerability.

Direct download: GRACEcast-133_Breast-Video_Functional_Assessment_of_Pts_4.m4v
Category:Breast-Cancer-Video -- posted at: 4:25pm PST

Dr. Hy Muss reviews potential benefits of treatment for advanced, metastatic breast cancer, as well as the value of functional assessment of patients to predict treatment tolerability.

Direct download: GRACEcast-133_Breast-Audio_Functional_Assessment_of_Pts_4.mp3
Category:Breast-Cancer-Audio -- posted at: 4:25pm PST

Dr. Jack West wishes the cancer community a happy holiday season from GRACE.

Direct download: GRACEcastUC-011_CA-101-Video_Happy_Holidays_Dr_West_GRACE.m4v
Category:Cancer-101-Video -- posted at: 5:16pm PST

Dr. Jack West describes a potentially efficient way to improve delivery of increasingly specialized care to broad geographic areas by collaboration of healthcare network teams using telemedicine solutions currently available.


Dr. Hy Muss, expert in breast cancer and geriatric oncology at the University of North Carolina at Chapel Hill, discusses leading surgery options for breast cancer and how we estimate the value of post-operative therapy.


Dr. Hy Muss, expert in breast cancer and geriatric oncology at the University of North Carolina at Chapel Hill, discusses leading surgery options for breast cancer and how we estimate the value of post-operative therapy.


Dr. Jack West discusses the pros and cons of repeat biopsies of tumors in the setting of "acquired resistance" to targeted therapies, with a specific consideration of whether this should be considered a standard of care.

Direct download: GRACEcastUC-009_CA-101-Video_Repeat_Biopsies_with_Progression.m4v
Category:Cancer-101-Video -- posted at: 8:00am PST

Dr. Jack West reviews the limitations of artificial intelligence applied to clinical decision-making in complex cases in oncology, and why Dr. Watson won't necessarily become the perfect oncologist.


Dr. Dara Aisner, Pathologist at the University of Colorado, describes emerging technological changes that will advance how molecular marker testing is done, to make it faster and more complete over time.

Direct download: GRACEcast-131_CA-101-Audio_Future_of_Molecular_Pathology_3.mp3
Category:Cancer-101-Audio -- posted at: 8:00am PST